Zytiga 250
Drug Category |
|
Medicinal form |
Tablets |
Active ingredient |
|
Concentration |
250mg |
Manufacturer |
|
Price |
21685 EGP |
Uses
used in combination with prednisone in metastatic castration-resistant prostate cancer (formerly hormoneresistant or hormone-refractory prostate cancer) - i.e., prostate cancer not responding to androgen deprivation or treatment with antiandrogens.
Uses: metastatic castration-resistant prostate cancer (CRPC) in patients who are chemotherapy-I or in those who have received prior chemotherapy containing docetaxel; administer with prednisone 4tabs (1000mg) PO qDay with prednisone 5mg PO q12hr.
Note: The information provided about this drug does not substitute for consulting a doctor.
Related medicines
Proleukin 18
650 EGP
Paclitax 150 - Cipla LTD/Star International
1100 EGP
Paclitax 150 - Actavis/Multi-Pharma
1400 EGP
Imuran 50
50 EGP
Vinracine 1
29 EGP
Methotrexate 2.5 - Acdima
105 EGP
Emepitanr Capsules
320 EGP
Alkyloxan 50
62 EGP
Leukeran 2
3 EGP
Treczimus 0.03%
38 EGPThe doctor answers your questions quickly
Are you experiencing any symptoms at the moment? Now many specialist doctors are ready to help you.
Calculators
Calculator for Health is a very useful tool to help individuals better understand and manage their health. By providing measurable data, users can make better informed decisions to maintain or improve their well-being.
Direct Access to Pharmacy Through Innovative Portal
Empower your health journey with Direct Access to Pharmacy Through Innovative Portal - Your gateway to seamless and efficient healthcare solutions at your fingertips
See list pharmacies